What the OraQuick In-Home HIV Test Means for HIV Treatment and Prevention: A Panel Discussion
May 25, 2012
On March 15, an FDA panel voted unanimously that the OraQuick In-Home HIV Test from OraSure Technologies, Inc., was safe and effective for determining a person's HIV status. The OraQuick test is poised to become the first over-the-counter, in-home HIV test on the market.
AIDS United Senior Vice President Vignetta Charles and Vice President of Policy and Advocacy Ronald Johnson were joined by Ed Gadson, a Client Advocate with the community-based organization Helping Individual Prostitutes Survive (HIPS), to discuss the implications of the OraQuick In-Home HIV Test on HIV treatment and prevention efforts.
Watch the video of the panel discussion:
This article was provided by AIDS United. Visit AIDS United's website to find out more about their activities and publications.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)